Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sublingual Versus Vaginal Misoprostol for Induction of Labor for Primigravida at 41 or More Weeks of Pregnancy: A Randomized Clinical Trial

NCT04887493 is registered in ClinicalTrials.gov with Ministry of Health, Bhutan as lead sponsor.

NCT NCT04887493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04887493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sublingual Versus Vaginal Misoprostol for Induction of Labor for Primigravida at 41 or More Weeks of Pregnancy: A Randomized Clinical Trial
Lead sponsor
Ministry of Health, Bhutan
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2021
Completion date
November 30, 2021
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induction of labour